Hagos Tesfay Tesfay Medhin

Dr. Hagos Tesfay Tesfay Medhin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EZEmeshaw Damtew Zebene
Emeshaw Damtew Zebene
RLRita Lombardi
Rita Lombardi
BPBiagio Pucci
Biagio Pucci
Hagos Tesfay Tesfay MedhinHagos Tesfay Tesfay Medhin
Hagos Tesfay Tesfay Medhin
EWEdom Woldetsadik
Edom Woldetsadik
GBGurja Belay
Gurja Belay
Head and neck cancers (HNCs) are the sixth most commonly diagnosed cancer and the eighth leading cause of cancer-related mortality worldwide, with squamous cell carcinoma being the most prevalent type. The global incidence of HNCs is steadily increasing, projected to rise by approximately 30% per year by 2030, a trend observed in both developed and undeveloped countries. This study involved serum proteomic profiling to identify predictive clinical biomarkers in cancer patients undergoing chemoradiotherapy (CRT). Fifteen HNC patients at Tikur Anbessa Specialized Hospital, Radiotherapy (RT) center in Addis Ababa were enrolled. Serum samples were collected before and after RT, and patients were classified as responders (R) or non-responders (NR). Protein concentrations in the serum were determined using the Bradford assay, followed by nano-HPLC–MS/MS for protein profiling. Progenesis QI for proteomics identified 55 differentially expressed proteins (DEPs) between R and NR, with a significance of p < 0.05 and a fold-change (FC) ≥ 1.5. The top five-up-regulated proteins included MAD1L1, PSMC2, TRIM29, C5, and SERPING1, while the top five-down-regulated proteins were RYR1, HEY2, HIF1A, TF, and CNN3. Notably, about 16.4% of the DEPs were involved in cellular responses to DNA damage from cancer treatments, encompassing proteins related to deoxyribonucleic acid (DNA) damage sensing, checkpoint activation, DNA repair, and apoptosis/cell cycle regulation. The analysis of the relative abundance of ten proteins with high confidence scores identified three DEPs: ADIPOQ, HEY2, and FUT10 as potential predictive biomarkers for treatment response. This study highlighted the identification of three potential predictive biomarkers—ADIPOQ, HEY2, and FUT10—through serum proteomic profiling in HNC patients undergoing RT, emphasizing their significance in predicting treatment response.

6 November 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
Masresha Ahmed AssayeMasresha Ahmed Assaye
Masresha Ahmed Assaye
Marinella De LeoMarinella De Leo
Marinella De Leo
DVDuccio Volterrani
Duccio Volterrani
Hagos Tesfay Tesfay MedhinHagos Tesfay Tesfay Medhin
Hagos Tesfay Tesfay Medhin
FTFrehiwot Teka
Frehiwot Teka
SGSolomon Genet Gebre
Solomon Genet Gebre
Phytochemical profiles, antioxidant, and anti-inflammatory activities were assessed in methanolic extracts of Moringa oleifera (L.) Lam. and Moringa stenopetala (Bak.) Cufod. leaves, using a workflow from plant collection to lab assays.

17 March 2025 in Cancers
Verified
Journal Article
Open access
PDF file
EZEmeshaw Damtew Zebene
Emeshaw Damtew Zebene
BPBiagio Pucci
Biagio Pucci
RLRita Lombardi
Rita Lombardi
Hagos Tesfay Tesfay MedhinHagos Tesfay Tesfay Medhin
Hagos Tesfay Tesfay Medhin
EWEdom Woldetsadik
Edom Woldetsadik
GBGurja Belay
Gurja Belay
Background: Ionizing radiation (IR) exposure poses a significant health risk due to its widespread use in medical diagnostics and therapeutic applications, necessitating rapid and effective biomarkers for assessment. Objective: The aim of this study is to identify the serum proteomic signature of IR exposure in patients undergoing radiotherapy (RT). Methods: Blood samples were obtained from eighteen patients with head and neck cancer (HNC) and five patients with rectal cancer before and immediately after they underwent curative intensity-modulated radiotherapy (IMRT). The comprehensive serum proteome was analyzed in individual samples using nanoHPLC-MS/MS. Results: Forty radiation-modulated proteins (RMPs), 24 upregulated and 16 downregulated, with a fold change ≥1.5 and p-value < 0.05 were identified. About 40% of the RMPs are involved in acute phase response, DNA repair, and inflammation; the key RMPs were ADCY1, HGF, MCEMP1, CHD4, RECQL5, MSH6, and ZNF224. Conclusions: This study identifies a panel of serum proteins that may reflect the radiation response, providing a valuable molecular fingerprint of IR exposure and paving the way for the development of sensitive and specific biomarkers for early detection and clinical management of IR-related injuries.

23 January 2026 in medRxiv
Verified
Preprint
Open access
PDF file
EAEden Alemu
Eden Alemu
AMAbebe Melis
Abebe Melis
AAAlemwosen Teklehaymanot Alem
Alemwosen Teklehaymanot Alem
BFBizunesh Dires Fenta
Bizunesh Dires Fenta
AFAnteneh Fikrie
Anteneh Fikrie
AAAbdela Amano
Abdela Amano
Introduction: Anemia is a common and debilitating complication in cancer patients, affecting prognosis, quality of life, and treatment response. The burden of anemia may be higher in resource-limited settings due to nutritional deficiencies and limited healthcare access. However, data on anemia among newly diagnosed cancer patients in Ethiopia remain scarce. This study was aimed to determine the magnitude and predictors of anemia in newly diagnosed adult solid cancer patients in Hawassa, Ethiopia. Methods: A cross-sectional study was conducted among randomly selected 405 newly diagnosed adult solid cancer patients at selected public health facilities in Hawassa City, Ethiopia, from June 2021 to October 2021. Data were collected using structured face-to-face interviews and from medical records. Data were entered into EpiData version 3.1 and exported to SPSS version 26 for analysis. Descriptive statistics were computed for all variables. Binary logistic regression was performed to determine the independent effects of potential explanatory variables on the presence of anemia. Adjusted Odds ratios with 95% confidence intervals were calculated. Statistical significance was set at p-value < 0.05. Result: The prevalence of anemia was 26.4% (95% CI: 22.1–30.7%), with normocytic anemia (56.1%) being the most common morphological type. Multivariable analysis identified a history of bleeding (AOR = 3.46, 95% CI: 1.94–6.16), advanced cancer stage (AOR = 2.01, 95% CI: 1.20–3.34), and underweight BMI (AOR = 2.14, 95% CI: 1.28–3.55) were significantly associated with anemia. Conversely, higher educational attainment (diploma and above) was protective (AOR = 0.35, 95% CI: 0.13–0.93). Conclusion: Anemia affects over one-quarter of newly diagnosed solid cancer patients in Hawassa, with advanced-stage disease, bleeding history, and decreasing body mass index as significant risk factors. These findings highlight the need for routine anemia screening at diagnosis, nutritional interventions, and early bleeding management in oncology settings.